Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.06

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.06). Revenue for the quarter came in at $8.3 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• Macy's (M) PT Raised to $25 at TD Cowen
• Increasing unusual option volume: XIFR DOMO GDS COLO CRDF IMRX BFLY WMB STRC ERAS SGMT SGOL HELP